臨床試驗

A Study of Selective Internal Radiation Therapy for the Management of Chemotherapy-induced Thrombocytopenia With Splenomegaly in Adult Subjects With Gastrointestinal Cancer

NCT：NCT07575854 · NOT_YET_RECRUITING

NCT IDNCT07575854

狀態NOT_YET_RECRUITING

開始日期2026-10-01

完成時間2029-04-01

SponsorCentre Georges Francois Leclerc (OTHER)

First posted2026-05-08

Last updated2026-05-13

簡要摘要

This is a prospective, interventional, open-label, single-arm, multicenter pilot study evaluating the safety, tolerability and maximum tolerated dose (MTD) of splenic Selective Internal Radiation Therapy (SIRT) using TheraSphere in adult patietns with gastrointestinal cancer and chemotherapy-induced thrombocytopenia with splenomegaly

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。